Frontiers in Drug Delivery aims to be the leading international journal in drug delivery, publishing rigorously peer-reviewed research ranging from basic concepts at a cell and tissue level through to translational outcomes for drug formulations and formulations combined with devices.Read More
Frontiers in Drug Delivery aims to be the leading international journal in drug delivery, publishing rigorously peer-reviewed research ranging from basic concepts at a cell and tissue level through to translational outcomes for drug formulations and formulations combined with devices. Its six Specialty Sections cover key delivery routes (oral, brain targeting, ocular, and dermatological) as well as a focus on important specific disease or product areas where delivery can play an important role (cardiovascular drug delivery and vaccine delivery), a hybrid model. Its flexible structure will allow addition of new Specialty Sections as drug delivery science further develops.
Drug delivery is practiced by multi-disciplinary teams across academia and industry. It has relied traditionally on expertise drawn from pharmaceutical sciences, pharmacology and physiology, bioengineering, material science, medicinal chemistry, tissue engineering, mathematical modelling, and clinical trial design. To these disciplines can be added artificial intelligence research to trigger drug release and to provide feedback to remote systems, as well as computational design of formulation components, 3-D printing of tablets and implants, and sophisticated in silico and in vitro assays of drug performance in body compartments. Frontiers in Drug Delivery will therefore provide an all-encompassing Open Access resource for original high quality delivery research which is currently splintered across more than a dozen journals. With the unique collaborative role of referees in the process of producing final articles for Frontiers, readers can be assured of transparent processes leading to high-quality articles, reviews, Insights, and Research Topics in drug delivery upon which the Frontiers franchise has built its reputation over the past fourteen years.
Field Chief Editor, David Brayden, from University College Dublin is supported by an outstanding group of international Speciality Editors across the six Specialty Sections, each with their own team of Associate Editors, all of whom are established or newly established top quality delivery researchers. This multidisciplinary open-access journal will therefore be at the forefront of disseminating and communicating scientific knowledge and impactful discoveries on drug delivery to researchers, academics, clinicians, and the public worldwide.
Short Name: Front. Drug. Deliv.
Indexed in: Google Scholar, CrossRef, CLOCKSS, OpenAIRE
Frontiers in Drug Delivery is composed of the following Specialty Sections:
The specialty sections of Frontiers in Drug Delivery welcome submission of the following article types: Brief Research Report, Case Report, Clinical Trial, Community Case Study, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Policy Brief, Protocols, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
When submitting a manuscript to Frontiers in Drug Delivery, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com